Profile data is unavailable for this security.
About the company
Science in Sport plc is a United Kingdom-based performance nutrition company. The Company is engaged in the sports nutrition business that develops, manufactures, and markets nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two brands, PhD Nutrition, an active-nutrition brand targeting the active lifestyle community, and Science in Sport (SiS), an endurance nutrition brand among athletes and professional sports teams. Its PhD Nutrition brand comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. Its SiS brand includes gels, powders and bars focused on energy, hydration, and recovery. The two brands sell through its phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and ebay, and retail distribution in the United Kingdom and internationally, including supermarkets, high street chains and specialist sports retailers.
- Revenue in GBP (TTM)65.93m
- Net income in GBP-7.07m
- Incorporated2013
- Employees158.00
- LocationScience in Sport PLC16-18 Hatton GardenLONDON EC1N 8ATUnited KingdomGBR
- Phone+44 128 244 0980
- Fax+44 128 244 0981
- Websitehttp://www.scienceinsport.com/us/about
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OptiBiotix Health PLC | 689.10k | -13.17m | 17.38m | 3.00 | -- | 1.73 | -- | 25.23 | -0.1489 | -0.1489 | 0.0078 | 0.1029 | 0.0426 | 2.28 | 1.25 | 229,700.00 | -81.35 | 17.83 | -83.43 | 18.66 | 49.31 | 54.87 | -1,911.88 | 190.54 | 3.24 | -0.089 | 0.00 | -- | -79.35 | 19.05 | -58.68 | 6.28 | 30.03 | -- |
| Oncimmune Holdings PLC | 1.15m | -6.15m | 18.16m | 56.00 | -- | 27.65 | -- | 15.77 | -0.0859 | 0.0507 | 0.0159 | 0.0089 | 0.1239 | 1.08 | 0.5941 | -- | -66.15 | -- | -131.46 | -- | 68.75 | -- | -533.94 | -- | 3.75 | -1.96 | 0.8897 | -- | -- | -- | -- | -- | -- | -- |
| Skinbiotherapeutics PLC | 161.65k | -2.88m | 18.54m | 11.00 | -- | 4.82 | -- | 114.66 | -0.0165 | -0.0165 | 0.0009 | 0.0192 | 0.0522 | 0.8871 | 0.4181 | 14,695.45 | -93.07 | -52.07 | -115.26 | -57.33 | 62.90 | -- | -1,784.70 | -4,694.37 | 6.48 | -379.78 | 0.0259 | -- | 76.65 | -- | -1.52 | -- | 18.00 | -- |
| LungLife AI Inc | 36.91k | -4.34m | 18.68m | 19.00 | -- | 1.24 | -- | 506.09 | -0.1704 | -0.1704 | 0.0015 | 0.2492 | 0.0038 | -- | 0.1474 | 1,942.90 | -44.11 | -- | -50.09 | -- | 100.00 | -- | -11,767.39 | -- | -- | -- | 0.0419 | -- | 91.67 | -- | 28.83 | -- | -- | -- |
| Verici DX PLC | 15.25k | -9.00m | 18.78m | 14.00 | -- | 2.46 | -- | 1,231.50 | -0.0528 | -0.0528 | 0.00009 | 0.0315 | 0.0013 | -- | 0.1152 | 1,016.50 | -77.76 | -- | -92.28 | -- | 84.21 | -- | -59,015.79 | -- | -- | -- | 0.0232 | -- | -- | -- | -36.94 | -- | -- | -- |
| Destiny Pharma PLC | 0.00 | -5.97m | 20.49m | 20.00 | -- | 1.72 | -- | -- | -0.0759 | -0.0759 | 0.00 | 0.1251 | 0.00 | -- | -- | 0.00 | -48.68 | -47.98 | -52.87 | -52.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -21.80 | -- | -45.97 | -- |
| Hemogenyx Pharmaceuticals PLC | 0.00 | -7.17m | 21.58m | 14.00 | -- | 5.01 | -- | -- | -0.007 | -0.007 | 0.00 | 0.0032 | 0.00 | -- | -- | 0.00 | -95.17 | -73.59 | -107.02 | -86.78 | -- | -- | -- | -- | -- | -71.62 | 0.4735 | -- | -- | -- | 21.96 | -- | 46.18 | -- |
| C4X Discovery Holdings PLC | 24.68m | 10.57m | 23.77m | 49.00 | 2.25 | 0.9662 | 2.18 | 0.9632 | 0.0419 | 0.0419 | 0.0979 | 0.0976 | 1.18 | -- | 5.02 | 503,673.50 | 50.37 | -66.17 | 55.00 | -76.79 | 99.94 | 97.43 | 42.81 | -416.04 | -- | -- | 0.0104 | -- | -36.64 | -24.70 | -36.16 | -- | -16.37 | -- |
| Oxford Biodynamics PLC | 510.00k | -10.83m | 28.07m | 45.00 | -- | 3.01 | -- | 55.03 | -0.0729 | -0.0729 | 0.0035 | 0.0299 | 0.0371 | 0.7987 | 0.332 | 11,333.33 | -78.82 | -39.72 | -105.32 | -45.52 | 52.16 | -- | -2,122.75 | -1,324.62 | 1.72 | -7.50 | 0.5154 | -- | 231.17 | -15.53 | -61.34 | -- | -1.60 | -- |
| Science in Sport PLC | 65.93m | -7.07m | 28.71m | 158.00 | -- | 0.7213 | -- | 0.4354 | -0.0464 | -0.0464 | 0.4239 | 0.2184 | 0.8479 | 4.20 | 3.83 | 417,278.50 | -9.09 | -9.69 | -13.75 | -11.97 | 41.88 | 47.09 | -10.72 | -11.94 | 0.6921 | -2.31 | 0.2825 | -- | 1.97 | 32.50 | -96.47 | -- | 49.81 | -- |
| CRUSHMETRIC Group Ltd | 399.37k | -881.75k | 30.03m | 20.00 | -- | 1.17 | -- | 75.18 | -0.0072 | -0.0072 | 0.0028 | 0.1065 | 0.0255 | 7.14 | 2.64 | 19,968.74 | -5.72 | -40.65 | -8.35 | -- | 34.66 | 37.39 | -224.56 | -140.54 | 0.072 | -14.42 | 0.0558 | -- | 119.19 | -1.40 | -7.26 | -- | 12.11 | -- |
| Sareum Holdings Plc | 0.00 | -4.26m | 31.90m | 5.00 | -- | 51.39 | -- | -- | -0.0614 | -0.0614 | 0.00 | 0.0059 | 0.00 | -- | -- | 0.00 | -160.20 | -71.41 | -195.05 | -81.48 | -- | -- | -- | -19,709.24 | -- | -6.61 | 0.00 | -- | -- | -- | -46.96 | -- | -- | -- |
| Redx Pharma PLC | 4.20m | -33.16m | 35.98m | 101.00 | -- | 9.23 | -- | 8.56 | -0.099 | -0.099 | 0.0126 | 0.01 | 0.0954 | -- | 135.55 | 41,603.96 | -75.26 | -52.99 | -166.19 | -88.10 | -- | -- | -789.05 | -206.66 | -- | -- | 0.8405 | -- | -77.52 | 100.71 | -84.15 | -- | 8.12 | -- |
| Arecor Therapeutics PLC | 3.38m | -9.42m | 41.81m | 51.00 | -- | 3.16 | -- | 12.37 | -0.3108 | -0.3108 | 0.1114 | 0.4314 | 0.1805 | -- | 0.7516 | 66,254.90 | -50.32 | -- | -66.40 | -- | -- | -- | -278.81 | -- | 2.28 | -- | 0.0125 | -- | 107.51 | -- | -50.11 | -- | -- | -- |
Data as of Apr 24 2024. Currency figures normalised to Science in Sport PLC's reporting currency: UK Pound GBX
74.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd.as of 03 Jan 2024 | 46.94m | 25.75% |
| Otus Capital Management Ltd.as of 16 Aug 2023 | 19.55m | 10.73% |
| J.O. Hambro Capital Management Ltd.as of 16 Aug 2023 | 15.30m | 8.39% |
| Aviva Investors Global Services Ltd.as of 16 Aug 2023 | 14.67m | 8.05% |
| Sarasin & Partners LLPas of 16 Aug 2023 | 11.13m | 6.11% |
| Schroder Investment Management Ltd.as of 12 Apr 2023 | 10.93m | 6.00% |
| River Global Investors LLPas of 16 Aug 2023 | 8.16m | 4.47% |
| LGT Capital Partners AG (Investment Management)as of 31 May 2023 | 4.38m | 2.40% |
| Canaccord Genuity Wealth Ltd.as of 30 Sep 2022 | 2.40m | 1.32% |
| Roce Capital SASas of 27 Oct 2022 | 1.79m | 0.98% |
More ▼
Data from 27 Oct 2022 - 01 Apr 2024Source: FactSet Research Systems Inc.
